Kinfo
Accuray Incorporated logo

Accuray Incorporated

ARAYNASDAQHealthcare·US · USD
$0.11
-0.01 (-8.33%)
Prices as of November 6, 2026 · market closed

Price

Key statistics

Valuation
Market cap14.33M USD
Enterprise value161.06M USD
Trailing P/E-0.28
Forward P/E-0.52
PEG ratio0.00
Price / sales0.04
Price / book0.36
Profitability
Gross margin34.76%
Operating margin6.21%
Profit margin-12.24%
Return on assets-1.40%
Return on equity-80.08%
Income (TTM)
Revenue401.95M USD
Gross profit111.45M USD
EBITDA-3.53M USD
Net income-49.19M USD
Diluted EPS-$0.40
Rev. growth (YoY)-20.90%
Balance sheet
Total cash40.62M USD
Total debt183.87M USD
Debt / equity440.96
Current ratio1.50
Book value / share$0.35
Cash flow (TTM)
Operating cash flow-6.98M USD
Levered free cash flow10.57M USD
Shares & price
Shares outstanding119.43M
Float113.42M
Held by institutions64.48%
Beta1.38
50-day MA$0.22
200-day MA$0.36
52-week high$1.27
52-week low$0.11
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-10-1313.0917.01+29.95%2026-06-11-0.33-0.09+72.73%2026-05-202.913.09+6.19%2026-05-06-0.05-0.07−40.00%2026-02-04-0.11-0.11+0.00%
About Accuray Incorporated

Accuray Incorporated is a medical device company that develops, manufactures, sells, and supports advanced radiation therapy systems for cancer treatment. The company’s portfolio centers on the CyberKnife and Radixact platforms, which are designed to deliver precise, image-guided treatments for tumors and other complex clinical cases. Accuray also provides treatment planning software, motion management tools, and service offerings that support hospitals, cancer centers, and academic medical institutions. Its products are used across radiation oncology, stereotactic radiosurgery, and other specialized treatment workflows, giving the company a role in the broader market for precision oncology technologies. Accuray Incorporated focuses on combining hardware, software, and clinical support to help healthcare providers deliver targeted radiation therapy with greater accuracy and flexibility.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Stephen R. LaNeve MBA
Employees
809
Headquarters
Madison, WI, United States

Frequently asked questions about Accuray Incorporated